Epsilon Healthcare Limited (AU:EPN)
ASX:EPN
EPN Stock Chart & Stats
AU$0.02
AU$0.00(0.00%)
At close: 4:00 PM EDT
AU$0.02
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.02 - AU$0.04
Previous CloseN/A
Volume222.34K
Average Volume (3M)0.00
Market Cap
AU$8.56M
Enterprise ValueAU$22.48M
Total Cash (Recent Filing)AU$242.86K
Total Debt (Recent Filing)AU$14.16M
Price to Earnings (P/E)―
Beta-0.15
Next Earnings
Sep 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding389,104,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)4.19
Price to Sales (P/S)1.33
P/FCF Ratio-3.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
CGMP Manufacturing CapabilityOwning cGMP-compliant extraction and manufacturing facilities provides a durable operational advantage: regulatory readiness, consistent product quality, and the ability to offer private-label manufacturing. These capabilities support long-term B2B contracts and higher barriers to entry versus asset-light competitors.
Material Revenue ReboundA ~53% revenue rebound in 2025 signals recovering demand and the company's ability to scale sales after prior weakness. If sustained, stronger top-line momentum improves operating leverage potential and provides a pathway to absorb fixed costs and move toward profitability over the medium term.
Improved Unit Economics (gross Profit)Positive gross profit in 2025 indicates the core production and product mix generate excess over direct costs. This suggests improving unit economics; with continued revenue growth and disciplined overhead control, the company has a structural opportunity to convert gross profit gains into sustainable operating profits.
Bears Say
Persistent Cash BurnConsistent negative operating and free cash flow means the business consumes cash to run, forcing reliance on external funding or asset sales. Over months this reduces strategic flexibility, risks dilution if equity is issued, and makes investments or scaling dependent on accessible financing.
Marked Rise In LeverageDebt-to-equity near 4.7x represents materially higher financial risk versus prior years. Elevated leverage limits ability to absorb shocks, increases interest and refinancing exposure, and constrains capital allocation. If losses persist, leverage amplifies insolvency risk over a multi-month horizon.
Sustained Net Losses / Negative MarginsNet margins around -22% show the company has yet to translate revenue gains into profitability. Persistent losses erode equity, reduce retained earnings, and hinder long-term capital accumulation. Without structural margin improvement, profitability remains uncertain despite top-line recovery.
Epsilon Healthcare Limited News
EPN FAQ
What was Epsilon Healthcare Limited’s price range in the past 12 months?
Epsilon Healthcare Limited lowest share price was AU$0.02 and its highest was AU$0.04 in the past 12 months.
What is Epsilon Healthcare Limited’s market cap?
Epsilon Healthcare Limited’s market cap is AU$8.56M.
When is Epsilon Healthcare Limited’s upcoming earnings report date?
Epsilon Healthcare Limited’s upcoming earnings report date is Sep 02, 2026 which is in 151 days.
How were Epsilon Healthcare Limited’s earnings last quarter?
Epsilon Healthcare Limited released its earnings results on Feb 27, 2026. The company reported AU$0.002 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.002.
Is Epsilon Healthcare Limited overvalued?
According to Wall Street analysts Epsilon Healthcare Limited’s price is currently Overvalued.
Does Epsilon Healthcare Limited pay dividends?
Epsilon Healthcare Limited does not currently pay dividends.
What is Epsilon Healthcare Limited’s EPS estimate?
Epsilon Healthcare Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Epsilon Healthcare Limited have?
Epsilon Healthcare Limited has 389,104,000 shares outstanding.
What happened to Epsilon Healthcare Limited’s price movement after its last earnings report?
Epsilon Healthcare Limited reported an EPS of AU$0.002 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Epsilon Healthcare Limited?
Currently, no hedge funds are holding shares in AU:EPN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Epsilon Healthcare Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth AU$30.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Fundamentals
Return on Equity
649.03%
Trailing 12-Months
Asset Growth
84.04%
Trailing 12-Months
Company Description
Epsilon Healthcare Limited
Epsilon Healthcare Limited (EPN) is an innovative healthcare company focused on developing and commercializing a range of therapeutic products and services. Operating primarily in the biotechnology and pharmaceutical sectors, EPN specializes in cannabinoid-based therapies aimed at enhancing patient care and improving health outcomes. The company is dedicated to research and development, aiming to leverage cutting-edge science to create effective, safe, and reliable healthcare solutions for various medical conditions.
Technical Analysis
Vita Life Sciences Limited
―
Little Green Pharma Ltd.
―
Medical Developments International Limited
―
Althea Group Holdings Ltd.
―
IDT Australia Limited
―